ICS 2023, 27-29 September in Toronto, will be a great 3-day meeting offering a range of sessions and topics depending upon your speciality and interests.

The ICS annual meeting brings together the most renowned international experts in the research and the treatment of incontinence, pelvic floor disorders and LUTS. The meeting is multidisciplinary and welcomes urologists, gynaecologists, neurourologists, physiotherapists, nurses, midwives, research scientists, and everyone dedicated to improving the lives of those with continence related issues.

Expect to hear from world-class leaders in the field. The ICS state-of-the-art lectures, round table debates and discussions will bring to you cutting-edge information, and our workshops this year will focus on hands-on skills. There will also be the Physiotherapy Forum, the Nurses Forum, Early Career Sessions, and Networking Functions. In addition, our exhibitors will present the latest in technology.

Key Dates:
Workshop submission: 1 November 2022 - 3 January 2023
Abstract submission: 1 February 2023 - 3 April 2023
Early registration deadline: 30 June 2023
ICS 2023 Annual Meeting: 27 September 2023

We look forward to meeting you in Toronto!

Read on go.evvnt.com

Join us in Vilnius for the 18th Scientific and Annual Conference of the European Society of Coloproctology. We are pleased to invite you to ESCP 2023 taking place from 27 to 29 September 2023. Save the date!

As ESCP works toward its aim of being the professional organisation in Europe for the prevention and treatment of colorectal disease through education, training and research, the annual ESCP Conference is an integral aspect of our activities toward achieving this.

ESCP 2023 provides an opportunity to increase your knowledge, and gain a better understanding of the most recent scientific advances in the field of coloproctology, while also allowing you to present your latest findings and interact with physicians and fellow industry specialists involved in our field.

Read on go.evvnt.com

Join your peers along with C-Suite, technology, marketing, and engagement executives to identify and implement novel strategies to bring care closer to consumers and elevate the member/patient experience.

• BUILD TRUST AND LOYALTY with consumers throughout their healthcare journey
• LEVERAGE LATEST TECHNOLOGICAL INNOVATIONS to drive healthcare forward
• BRAINSTORM IDEAS and NETWORK with health plan and hospital system executives to meaningful impact on the health and well-being of members and patients

Read on thinc360.com

Building on the success of the recent CDC-ONC Industry Days, the CDC Foundation is excited to host the CDC Health Data Innovation Summit. This event aims to unite key partners in addressing critical public health data challenges, including public health agencies, healthcare providers, academia, technology vendors, and industry experts. Join us in advancing health data innovation.

Read on himsschapter.org

The CDC Foundation announces the CDC Health Data Innovation Summit, a follow-up to the successful CDC-ONC Industry Days. Set on September 27-28, 2023, in Atlanta, GA, the event aims to unite partners and address crucial public health information challenges. Participants include representatives from various sectors, such as public health agencies, healthcare providers, academia, technology vendors, and more, all invested in overcoming health data obstacles.

Read on fbcinc.com

 The "8th International Conference on Future Pharma and Innovations," scheduled for September 27-28, 2023, in Amsterdam, Netherlands, and largely focused on the theme "Pioneering the Development of Future Pharma," is cordially invited to participants from all over the world.

With its well crafted systematized scientific programme, which features interactive panel discussions, keynote lectures, grand addresses, and bill Sessions, the event provides its audience with a chic stage. The Future of Pharma R&D, Industrial Pharmacy and Physical Drugstore, Drug Discovery and Development, Novel Drug Delivery Systems, and Pharma and Biotech Financial Outlook are some of the topics covered by the global platform Future Pharma.

Read on futurepharmameetings.pharmaceuticalconferences.com

Arena International are delighted to announce the Outsourcing in Clinical Trials Southern California Event will be returning to California’s La Jolla on September 26th & 27th 2023! Our leading clinical show will focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed- take a look at our agenda page & list of keynote speakers. The 2023 program boasts 2 streams jam packed with content. The Speaking Faculty includes the likes of AbbVie, Jazz Pharmaceuticals, Pfizer, Cortexyme, PTC Therapeutics, ReShape Lifesciences, Elevar Therapeuticsand many more. This is a a networking focused event with industry leading presentations, interactive formats and the most innovative solution providers attending. Attendees will hear from industry leading speakers, learn what is round the corner in terms of future trends and get the latest knowledge on new and upcoming disruptors.

Read on arena-international.com

The Fierce Clinical Summit is our flagship event for clinical professionals that covers multiple disciplines. We're bringing together attendees from three key clinical areas - Clinical Innovation, Clinical Governance and Oversight, and Clinical Quality. Professionals working with both internal and external stakeholders will come together to learn the latest innovations and best practices in their areas of concentration, plus be able to network with peers both in their area of concentration and across departments.

Read on go.evvnt.com

Growing consumer demand, technology advancement, and VC investment are feeding into the billion-dollar market opportunity for novel alternative proteins and cultured meat and seafood. To fully realize this potential, the commercial and technical burden of scale-up and downstream processing must be overcome.

The Downstream Processing (DSP) for Alternative Proteins and Cellular Agriculture Summit is your dedicated community to help you evaluate current DSP strategies to reduce cost, improve titer, and guarantee quality for commercial scalability.

Developed with leading companies in the space, here is a snapshot of this year's unmissable content across 3 hands-on workshops and 2 days of data-driven case studies: 

- Determine and define downstream processing based on the technical and commercial viability with Impossible Foods and Remilk

- Navigate the path to commercializing sustainable proteins from R and D scale with in-house process modelling with Motif FoodWorks

- Control the environment of a scaled-up growth facility for good proliferation with Orbillion Bio

- Develop scalable analytical frameworks to validate bioprocessing, characterize the product, and satisfy regulators with BlueNalu, Shiru, and Impossible Foods - - Validate contract manufacturing facilities and select the right equipment for pilot scale for smooth technology transfer with Helaina and Finless Foods

Read on go.evvnt.com

With the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable! However, with so many KRAS G12C drugs in clinic, the field is now turning its eyes to the next generation of RAS therapies, specifically those that can target more mutations, more RAS isoforms, and more indications And so, the 5th RAS Targeted Drug Development Summit arrives as the only industry-dedicated, end-to-end forum to accelerate your best-in-class RAS therapies from conception through to commercialization. As the only industry-dedicated, end-to-end meeting focused on the next-generation of drugs targeting RAS cancers, the 5th RAS Targeted Drug Development Summit will bring together 150+ key opinion leaders to accelerate RAS-targeted drug discovery, advance pre-clinical drugs to clinic, and optimize translational and clinical development.

Read on go.evvnt.com